Search

RHOEN-KLINIKUM AG

Abierto

12 -1.64

Resumen

Variación precio

24h

Actual

Mínimo

12.1

Máximo

12.3

Métricas clave

By Trading Economics

Ingresos

2.9M

9.9M

Ventas

9.8M

429M

P/B

Media del Sector

22.807

87.826

BPA

0.148

Rentabilidad por dividendo

0.78

Margen de beneficio

2.317

Empleados

19,041

EBITDA

1M

27M

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

0.78%

2.26%

Próximas Ganancias

26 mar 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

67M

870M

Apertura anterior

13.64

Cierre anterior

12

Puntuación técnica

By Trading Central

Confianza

Very Strong Bearish Evidence

RHOEN-KLINIKUM AG Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

7 ene 2026, 23:11 UTC

Ganancias

Samsung Electronics Expects Record Fourth-Quarter Profit Beat

7 ene 2026, 22:55 UTC

Principales Movimientos del Mercado

Defense Stocks Rebound After Trump Says He Wants $1.5 Trillion Military Budget in 2027

7 ene 2026, 21:39 UTC

Principales Movimientos del Mercado

Raytheon Down Following Trump Post Criticizing Company

7 ene 2026, 20:13 UTC

Principales Movimientos del Mercado

AbbVie, Revolution Medicines Stocks Gain on Report of Possible Acquisition

7 ene 2026, 20:03 UTC

Principales Movimientos del Mercado

Defense Contractor Shares Fall on Trump's Push to Ban Industry Dividends, Buybacks, Limit Executive Pay

7 ene 2026, 23:46 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

7 ene 2026, 23:46 UTC

Charlas de Mercado

Nikkei May Decline as China-Japan Tensions Linger -- Market Talk

7 ene 2026, 23:42 UTC

Adquisiciones, fusiones, absorciones

Warner Discovery Rejects Paramount's Amended Hostile Bid -- 5th Update

7 ene 2026, 23:34 UTC

Charlas de Mercado

Gold Edges Higher Amid Lingering Geopolitical Risks -- Market Talk

7 ene 2026, 23:29 UTC

Adquisiciones, fusiones, absorciones

Constellation Closes Deal for Calpine, Creating Biggest Electricity Generator -- Barrons.com

7 ene 2026, 22:48 UTC

Charlas de Mercado

Infratil's Discount to Net Asset Value Too Good to Ignore -- Market Talk

7 ene 2026, 22:46 UTC

Ganancias

Samsung Electronics Estimates 2025 Rev KRW332.770T Vs KRW300.870T >005930.SE

7 ene 2026, 22:45 UTC

Ganancias

Samsung Electronics Estimates 2025 Oper Pft KRW43.530T Vs KRW32.730T >005930.SE

7 ene 2026, 22:43 UTC

Adquisiciones, fusiones, absorciones

Revolution Medicines Draws Takeover Interest -- 2nd Update

7 ene 2026, 22:42 UTC

Ganancias

Samsung Electronics 4Q Oper Pft Estimate Beat FactSet-Compiled Consensus Forecast

7 ene 2026, 22:41 UTC

Ganancias

Samsung Electronics Sees 4Q Oper Pft KRW20.000T Vs KRW6.490T >005930.SE

7 ene 2026, 22:41 UTC

Ganancias

Samsung Electronics Sees 4Q Rev KRW93.000T Vs KRW75.790T >005930.SE

7 ene 2026, 22:40 UTC

Principales Movimientos del Mercado

Defense Stocks Rebound After Trump Says He Wants $1.5T Military Budget in 2027

7 ene 2026, 22:31 UTC

Charlas de Mercado

Macro Tailwinds Strengthen for Chalice Mining -- Market Talk

7 ene 2026, 22:22 UTC

Charlas de Mercado

Northern Star's Run of Disruptions Increasingly a Concern -- Market Talk

7 ene 2026, 22:01 UTC

Charlas de Mercado

Valuations of New Zealand Property Stocks Supportive -- Market Talk

7 ene 2026, 21:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

7 ene 2026, 21:46 UTC

Charlas de Mercado

Northern Star's Revised Guidance Looks Achievable -- Market Talk

7 ene 2026, 21:22 UTC

Adquisiciones, fusiones, absorciones

Eli Lilly to Buy Ventyx Biosciences for $14 a Share >LLY VTYX

7 ene 2026, 21:18 UTC

Adquisiciones, fusiones, absorciones

Lilly To Acquire Ventyx Biosciences To Advance Oral Therapies Targeting Inflammatory-mediated Diseases >LLY VTYX

7 ene 2026, 21:05 UTC

Adquisiciones, fusiones, absorciones

Warner Discovery Rejects Paramount's Amended Hostile Bid -- 4th Update

7 ene 2026, 20:29 UTC

Adquisiciones, fusiones, absorciones

AbbVie Near Deal for Revolution Medicines -- Update

7 ene 2026, 20:27 UTC

Charlas de Mercado

U.S. Natural Gas Futures Snap Losing Streak -- Market Talk

7 ene 2026, 19:58 UTC

Charlas de Mercado

Oil Falls As U.S. to Receive Sanctioned Venezuelan Crude -- Market Talk

7 ene 2026, 19:48 UTC

Principales Movimientos del Mercado

Defense Contractor Shares Fall on Trump's Push to Ban Industry Dividends, Buybacks, Limit Exec Pay

RHOEN-KLINIKUM AG Esperado

Consenso

By TipRanks

0 ratings

0

Comprar

0

Mantener

0

Vender

Puntuación técnica

By Trading Central

N/A / 15.2Soporte y Resistencia

Corto Plazo

Very Strong Bearish Evidence

Medio plazo

Strong Bearish Evidence

Largo Plazo

Neutral Evidence

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de RHOEN-KLINIKUM AG

RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, offers in-patient, semi-patient, and outpatient healthcare services in Germany. It also operates acute hospitals, medical care centers, and rehabilitation hospitals. The company was founded in 1973 and is based in Bad Neustadt an der Saale, Germany.
help-icon Live chat